Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aapro

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Histiocytic necrotizing lymphadenitis or Kikuchi's disease. Anatomo-clinical study of 4 casesC de Pree, M F Pelte, F Delacretaz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2015
Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)L Biganzoli, S Lichtman, J-P Michel, et al.
The Journal of Pediatrics|May 1, 1990
Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot studyD S Halpérin, P Wacker, G Lacourt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitantS Barbour, T Smit, X Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2010
Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapyM Aapro, A Fabi, F Nolè, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2015
Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentaryV A Morrison, P Hamlin, P Soubeyran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2009
Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) studyM Aapro, H Ludwig, C Bokemeyer, et al.
Cancer Treatment Reviews|November 19, 2016
Bone health in the elderly cancer patient: A SIOG position paperJ J Body, E Terpos, B Tombal, et al.
Tumori|July 1, 1995
Clinical efficacy of cancer subcutaneous immunotherapy with interleukin-2 in relation to the pretreatment levels of tumor growth factor insulin-like growth factor-1P Lissoni, S Barni, A Ardizzoia, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2000
New directions in the treatment of colorectal cancer: a look to the futureA Sobrero, D Kerr, B Glimelius, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Histiocytic necrotizing lymphadenitis or Kikuchi's disease. Anatomo-clinical study of 4 casesC de Pree, M F Pelte, F Delacretaz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2015
Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)L Biganzoli, S Lichtman, J-P Michel, et al.
The Journal of Pediatrics|May 1, 1990
Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot studyD S Halpérin, P Wacker, G Lacourt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitantS Barbour, T Smit, X Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2010
Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapyM Aapro, A Fabi, F Nolè, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2015
Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentaryV A Morrison, P Hamlin, P Soubeyran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2009
Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) studyM Aapro, H Ludwig, C Bokemeyer, et al.
Cancer Treatment Reviews|November 19, 2016
Bone health in the elderly cancer patient: A SIOG position paperJ J Body, E Terpos, B Tombal, et al.
Tumori|July 1, 1995
Clinical efficacy of cancer subcutaneous immunotherapy with interleukin-2 in relation to the pretreatment levels of tumor growth factor insulin-like growth factor-1P Lissoni, S Barni, A Ardizzoia, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2000
New directions in the treatment of colorectal cancer: a look to the futureA Sobrero, D Kerr, B Glimelius, et al.
Pageof 14